COPD Admissions Associated With Pulmonary Hypertension

by Phyllis Hanlon, Contributing Writer Pulmonary hypertension (PH) and chronic obstructive pulmonary disease (COPD) both affect breathing and heart function. They also sometimes occur at the same time. People with COPD often have a small amount of PH, as the pressure in the lungs may increase to accommodate changes in the lungs caused by COPD.

November 21st, 2017|

A Look at Pediatric Pulmonary Vascular Disease: Causes, Treatments and Outcomes

by Phyllis Hanlon, Contributing Writer Despite recent advances made in the understanding of pediatric pulmonary vascular disease (PVD) and pediatric pulmonary hypertension (PH), clinical care decisions are still limited by the lack of studies in these areas. A group of pediatric pulmonary researchers set out to look at what is currently known about the multiple

November 17th, 2017|

Managing Prostacyclin Side Effects

by Phyllis Hanlon, Contributing Writer The Food and Drug Administration (FDA) has approved 14 medications to treat patients with World Health Organization (WHO) Group 1 PH, pulmonary arterial hypertension (PAH). Eight of those drugs target components of the prostacyclin pathway, which helps to relax the blood vessels in the lungs. Even though these drugs

November 9th, 2017|

Report Looks at Factors that May Contribute to Cultural and Ethnic Differences in People Living with PAH

by Phyllis Hanlon, Contributing Writer The 2010 United States Census reported that about 36 percent of the population identifies as part of a racial or ethnic minority group. Studies have suggested that when minorities face health-related challenges – including WHO Group 1 PH (PAH, pulmonary arterial hypertension) – they often fare worse than the

October 27th, 2017|

Obesity and PAH: Research Project Looks at Survival Rates for Inpatients

by Phyllis Hanlon, Contributing Writer According to a statement from the American Heart Association ( and published in the medical journal Circulation, ( obesity has been associated with several other medical conditions, including heart disease. But an unusual phenomenon called the “obesity paradox” is when obese people with certain cardiovascular disorders are found to have

October 20th, 2017|

Understanding “Super Responders” May Drive Personalized Treatment

by Phyllis Hanlon, Contributing Writer Recent studies report that the future in health care lies in personalized medicine. Personalized medicine is a developing field of health care that takes into account individual clinical, genetic, environmental, behavioral and other factors in treating disease. This approach has been used successfully in some medical fields already, including

September 27th, 2017|

PHA Launches New Curriculum Series for Health Care Professionals Treating Rare, Often-Misdiagnosed Disease

Free Online CME Courses Focus on Fundamentals of Pulmonary Hypertension SILVER SPRING, Md. (September 26, 2017) – The Pulmonary Hypertension Association (PHA) is rolling out a new online 16-course CME curriculum series to promote quality patient care for people living with pulmonary hypertension (PH). The new series, “Pulmonary Hypertension: The Basics,” seeks to educate

September 26th, 2017|

Liver Transplantation and Mean Pulmonary Artery Pressure

by Phyllis Hanlon, Contributing Writer People with liver disease can develop a type of pulmonary hypertension (PH – high blood pressure in the lungs) called portopulmonary hypertension (POPH). POPH involves increased blood pressure and resistance in the arteries of the lungs in people who also have high blood pressure in the veins of the liver

September 20th, 2017|